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Abstract 
Background: Hericium erinaceus is an edible mushroom; its various pharmacological effects which have been investi‑
gated. This study aimed to demonstrate whether efficacy of oral administration of H. erinaceus mycelium (HEM) and its 
isolated diterpenoid derivative, erinacine A, can act as an anti‑neuroinflammatory agent to bring about neuroprotec‑
tion using an MPTP (1‑methyl‑4‑phenyl‑1,2,3,6‑tetrahydropyridine) mouse model of Parkinson’s disease, which results 
in motor disturbances, in addition to elucidating the mechanisms involved.
Methods: Mice were treated with and without HEM or erinacine A, after MPTP injection for brain injuries by the 
degeneration of dopaminergic nigrostriatal neurons. The efficacy of oral administration of HEM improved MPTP‑
induced loss of tyrosine hydroxylase positive neurons and brain impairment in the substantia nigra pars compacta as 
measured by brain histological examination.
Results: Treatment with HEM reduced MPTP‑induced dopaminergic cell loss, apoptotic cell death induced by 
oxidative stress, as well as the level of glutathione, nitrotyrosine and 4‑hydroxy‑2‑nonenal (4‑HNE). Furthermore, HEM 
reversed MPTP‑associated motor deficits, as revealed by the analysis of rotarod assessment. Our results demonstrated 
that erinacine A decreases the impairment of MPP‑induced neuronal cell cytotoxicity and apoptosis, which were 
accompanied by ER stress‑sustained activation of the IRE1α/TRAF2, JNK1/2 and p38 MAPK pathways, the expression of 
C/EBP homologous protein (CHOP), IKB‑β and NF‑κB, as well as Fas and Bax.
Conclusion: These physiological and brain histological changes provide HEM neuron‑protective insights into the 
progression of Parkinson’s disease, and this protective effect seems to exist both in vivo and in vitro.
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Background
Hericium erinaceus (Lion’s mane or Yamabushitake) is an 
edible mushroom with medicinal properties; it grows on 
old or dead broadleaf trees. It is used as a food and herbal 
medicine in Japan and China without harmful effects [1]. 
The mushroom may be a good candidate for inducing 
neuronal differentiation and promoting neuronal survival 
[2]. Both the mycelium (erinacines A-I) and the fruiting 
bodies (Hericenone C-H) are the source of many bioac-
tive extracts with drug efficacy. Hericium erinaceus has 
been extensively documented and possesses a range of 
therapeutic properties, such as antioxidant activity [3], 
hypolipidemic activity [4], hemagglutinating activity [5], 
antimicrobial activity [6], antiaging activity [7], immune 
modulation and anticancer activities [8, 9]. Erinacine 
A has small molecular weight components that are the 
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of H. erinaceus. These diterpenoid compounds also 
play a role in varied functions, including neuroprotec-
tion through nerve growth factor (NGF) synthesis [10]. 
Therefore, H. erinaceus is attracting attention as a novel 
resource, not only for medicinal drugs, but also for die-
tary phytochemicals for disease prevention and health 
promotion through use of its biological properties [11]. 
Our previous study focused on exploring the biological 
agent of erinacine A from H. erinaceus mycelium and its 
structural elucidation by ethanol extraction and HPLC 
analysis techniques [12, 13]. However, the mechanism by 
which H. erinaceus mycelium and its isolated diterpenoid 
derivative, erinacine A, promote neuron cell survival and 
protection from MPTP-induced neurotoxicity remains 
poorly understood, as does the mechanism by which H. 
erinaceus mycelium and erinacine A initiate neuropro-
tection against MPTP injury to the brain.
Parkinson’s disease (PD) involves a distinct sequence 
of events behind the selective neuronal death that 
occurs in PD, but these events are not fully understood 
[14–16]. Numerous diseases of the nervous system, such 
as Parkinson’s disease (PD) produce excessive free radi-
cal generation (reactive oxygen species [ROS] and reac-
tive nitrogen species [RNS]), which then cause oxidative 
damage. These include lipids, oxidative S-nitrosylation 
proteins and nucleic acids, which have been linked to 
apoptosis by the high levels of ROS in dopamine neurons 
due to dopamine metabolism. Various disease models 
for PD also show the involvement of the drug 1-methyl 
4-phenyl 1,2,3,6-tetrahydropyridine (MPTP) [17, 18]. 
Furthermore, the MPTP animal model is useful for the 
study of neurodegeneration in PD. The neurotoxic effects 
of MPTP are thought to be mediated by its metabolite 
1-methyl-4-phenylpyridinium ion (MPP+) and mono-
amine oxidase-B (MAO-B) in neuron cells, leading to a 
number of deleterious effects on cellular function, such 
as impairing the dopaminergic nigrostriatal neurons, 
generating free radicals from the mitochondria and a 
neuroinflammatory response, similar to those seen in PD 
[19, 20]. Our previous investigation focused on explor-
ing the biological agent of erinacine A from H. erinaceus 
mycelium, its structural elucidation by ethanol extrac-
tion and HPLC analysis techniques [12, 13]. However, 
the mechanism by which H. erinaceus mycelium and 
its isolated diterpenoid derivative, erinacine A, are able 
to effectively improve the neuroprotective effects of the 
endoplasmic reticulum (ER) stress pathway and apopto-
sis, as well as how the signal cascades become activated, 
remain poorly understood.
Numerous studies have demonstrated that the ER 
stress pathway might be crucial in various CNS degen-
erative diseases [21]. In fact, ER stress may be related to 
neuronal death. In particular, the JNK/p38 MAPK/CHOP 
pathways involved in ER-stress-induced apoptosis in the 
neurons are implicated in PD [22]. In addition, energy 
metabolism with cultured neuronal cells, including 
dopaminergic neurons, showed that MPP +  triggers ER 
stress and induces a number of genes [23]. Thus, extreme 
oxidant and peroxide levels from the neurotoxicity of 
MPTP suggest that inhibition of antioxidant defenses 
results in inflammatory effects and generation of ROS 
or RNS found in PD-related neuron damage [24, 25]. 
MPTP injury of the brain then induces oxidative stress, 
which leads to activate the multiple-cellular-signaling 
pathway, such as the IRE1α pathway. IRE1α binds TNF 
receptor-associated factor 2 (TRAF2), apoptosis signal-
regulating kinase 1 (ASK1) and downstream kinases that 
further activate Jun N-terminal kinase (JNK) and nuclear 
factor-κB (NF-κB), which has also been linked to PD [26, 
27]. In the present study, we explore the biological agent 
of H. erinaceus mycelium that is associated with protec-
tion against ER stress and loss of dopaminergic nigrostri-
atal neurons.
In our previous study, we investigated the molecular 
mechanisms underlying H. erinaceus that inhibit global 
cerebral ischemic injury via inactivation of the iNOS/
RNS and p38 MAPK/CHOP pathways, which may be 
among the possible pathways involved in stroke-related 
neuron injury [12, 13]. In the present study, we assess 
the neuroprotective effect of H. erinaceus mycelium and 
its isolated compound erinacine A, as well as its rele-
vance to idiopathic PD in the MPTP mouse model. We 
were able to demonstrate that H. erinaceus mycelium, a 
known antioxidant, is able to protect against the endo-
plasmic reticulum stress induced by the loss of dopamin-
ergic neurons and disordered motor function by MPTP 
injury. This results in its isolated compound erinacine A 
promoting neuronal cell survival due to MPP+ -medi-
ated induction expression of Fas and Bax via IRE1α/
TRAF2 complex formation and phosphorylation of the 
JNK1/2, p38 and NF-kB pathways. Moreover, developing 
more effective dietary H. erinaceus mycelium for PD is an 
important goal.
Methods
Hericium erinaceus extracts and analysis of erinacine A
Fresh mycelium of H. erinaceus was extracted with etha-
nol. The extract was concentrated and fractionated by 
solvent partition between ethylacetate and water. The 
ethylacetate fraction was subjected to silica gel column 
chromatography using n-Hexane–ethylacetate as the elu-
ent. The Hexane–acetone eluate was subjected to silica 
gel column chromatography according to the previous 
study [9, 12, 13]; HPLC analysis of erinacine A was exe-
cuted according to the previous study with minor modi-
fications. The analytical column used was a COSMOSIL 
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5C18-AR-II (250 ×  4.6  mm; particle size 5  μm, Nacalai 
USA, Inc., Kyoto, Japan). Separation was performed at 
40 °C using two different gradients for the mobile phase, 
which consisted of two solvents, methanol (A) and 2.0 % 
acetic acid in water (B). The gradient elution had the fol-
lowing profile: 0–20 min, 60–90 % (A); 20–25 min, 90 % 
(A). The retention time of erinacine A was approximately 
~17 min at a flow rate of 1.0 mL/min with a scanning UV 
wavelength at 340 nm. The 3 mg/g erinacine A in the H. 
erinaceus extracted with 85 % ethanol was confirmed and 
quantified by HPLC as shown in Fig. 1 [12, 13]. Chemical 
compounds studied in this article Erinacine A (PubChem 
CID: 10410568).
Animals
C57BL/6 mice (8–10  weeks old, 20–28  g) were kept 
individually in a 12-h light/dark cycle cage and had free 
access to water and food. Animal care and the general 
protocols for animal use were approved by the Institu-
tional Animal Care and Use Committee of Chang Gung 
University of Science and Technology. Mice were oper-
ated on according to the modified MPTP-induced PD’s 
model, can be induced by the intraperitoneal injections 
of MPTP-HCl (30 mg/kg; Sigma, St. Louis, MO) or saline 
in 5 day. Four groups (six mice in each group) were ran-
domly assigned to a sham control group, a MPTP group, 
three H. erinaceus wet mycelia (HEM) groups (5.38, 
10.76 and 21.52 mg) and erinacine A groups (1 mg/kg). 
HEM was dissolved in water (H2O) and mice received 
HEM oral administration indicated during the 25  days 
before the onset of MPTP induction and HEM starting 
after the first MPTP injection and continuing through 5 
additional days. Erinacine A was dissolved in dimethyl 
sulfoxide (DMSO) and administered intraperitoneally for 
5  days before the MPTP induction. The sham-operated 
group animals received an equivalent volume of saline. 
Mice were killed 5 days after MPTP injection and brains 
were harvested, sectioned, and processed [28].
Chemical reagents and antibodies
Mouse monoclonal antibodies against tyrosine phos-
pho-Hydroxylase (Ser31), GAPDH, β-actin, 4-Hydroxy-
2-nonenal (4-HNE), Nitro-tyrosine, CHOP, Fas, Bax, 
NFkB p65, Histone H1, TRAF2, IRE1α, and phospho-
IKB-β were purchased from Santa Cruz Biotechnology 
(Santa Cruz, CA, USA). Rabbit monoclonal antibod-
ies against phospho-p38 MAPK (Thr180/Tyr182) and 
phospho-JNK1/2 (Thr183/Tyr185) were purchased from 
Cell Signaling Technology (Beverly, MA, USA). The TdT-
mediated dUTP Nick End Labeling (TUNEL) kits were 
purchased from Roche (Germany). MPP+ (1-methyl-
4-phenylpyridinium), SDS, NP-40, while sodium deoxy-
cholate, protease inhibitor cocktail was purchased from 
Sigma (St. Louis, MO, USA).
Behavioral testing
Behavioral assessments on mice were made 1–6  days 
after MPTP injection. Motor performance was assessed 
with a rotary rod apparatus using a protocol similar to 
that described [29]. For the rotarod tests, the paradigms 
were used: rocking—direction of rotation with each full 
turn of the rod at 10 rpm for 3 min to a level just below 
the bottom of the rod. The mice were placed on the rotat-
ing rod and the time until they fell off was recorded. This 
















Fig. 1 Simplistic flow chart of neuroprotective activities of Hericium erinaceus mycelium (HEM) in a MPTP treated animal model
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was repeated six times until the total time on the rod for 
the control group was 3  min. Both the total time spent 
on the rotating rod for each mice, five groups (Control, 
MPTP, HEM), were recorded.
Immunohistochemistry
After the administration of a large dose of chloral 
hydrate, the mice were killed by decapitation 8 days after 
MPTP treatment. The brains were quickly removed and 
placed in ice-cold saline for 10  min. Next, the brains 
were cut into seven 4  μm-thickness slides transversely 
from neuron impairment area using a mouse brain 
matrix (Harvard Apparatus, MA, USA) and then imme-
diately fixed in 10  % formalin overnight. The brain sec-
tions were then dehydrated with graded ethanol, passed 
through chloroform, and embedded in paraffin, which 
were assessed by hematoxylin and eosin (H and E) stain-
ing. Paraffin sections of the striatum and substantia nigra 
were used for immunohistochemistry (IHC). Staining 
was performed using a biotinylated secondary antibody 
(Vectastain Universal Elite ABC Kit). Monoclonal rabbit 
antibodies against tyrosine Hydroxylase, nitro-tyrosine, 
4-HNE and Fas (CD95) were diluted in a ratio of 1:100. 
The omission of primary antibodies was used as the neg-
ative control. Using the slides, the presence of cytoplasm 
stained with brown was scored as positive. The protein 
expression were quantitatively evaluated using an Olym-
pus Cx31 microscope with an Image-pro Plus medical 
image analysis system. The digital images were captured 
using a digital camera (Canon A640). The positive area 
and optical density of the positive cells were determined 
by measuring three randomly selected microscopic fields 
(100×, 200× magnification) on each slide. The IHC index 
was defined as average integral optical density (AIOD) 
(AIOD = positive area × optical density/total area) [30].
Cell culture
The mouse N2a (Neuro-2a) cells were purchased from 
the American Tissue Culture Collection (ATCC, USA). 
Cells were grown in Dulbecco’s Modified Eagle Medium 
(DMEM) (Gibco) supplemented with 10  % fetal calf 
serum (Gibco), non-essential amino acids, 1 mM sodium 
pyruvate and 1 % antibiotics (100 units/mL of penicillin 
and 100  μg/mL of streptomycin). All experiments were 
performed in plastic tissue culture flasks, dishes or in 
microplates (Nunc, Naperville, Denmark). Incubation 
was carried out at 37  °C in a humidified atmosphere of 
5 % CO2 and 95 % air [31].
Assessment of cell viability and apoptosis assay
Cell viability, as previously reported by MTT quantitative 
colorimetric assay, was capable of detecting viable cells. 
The cells were seeded at 2  ×  104 cells/ml density and 
incubated with MPP +  for 24 h. Thereafter the medium 
was changed and incubated with MTT (0.5  mg/ml) for 
4  h. The viable cell number is directly proportional to 
the production of formazan following solubilization 
with isopropanol, which can be measured spectrophoto-
metrically at 563 nm [31]. Annexin V/propidium iodide 
(Biosource International, USA) was used to quantify the 
percentage of apoptosis cells. Flow cytometric analysis 
was performed with a FACSCaliber using CellQuest soft-
ware. Data were analyzed with CellQuest and WinMDI 
software. The apoptotic cells (V+/PI-) were measured by 
the fluorescence-activated cell sorter analysis in a FACS 
analyzer (Becton–Dickinson). The data represented three 
independent experiments [32].
Preparation of total cell extracts and immunoblotting 
analysis
Cells were lysed with a buffer containing 1  % NP-40, 
0.5 % sodium deoxycholate, 0.1 % sodium dodecyl sulfate 
(SDS) and a protease inhibitor mixture (phenylmethylsul-
fonyl fluoride, aprotinin and sodium orthovanadate). The 
total cell lysate (50 μg of protein) was separated by SDS–
polyacrylamide gel electrophoresis (PAGE) (12  % run-
ning, 4 % stacking) and analyzed by using the designated 
antibodies and the Western-Light chemiluminescent 
detection system (Bio-Rad, Hercules, CA), as previously 
described [31].
Statistical analyses
Data were reported as the mean  ±  standard devia-
tion (SD) of three independent experiments and were 
analyzed by one-way analysis of variance (ANOVA). 
The data were analyzed using the SAS software statisti-
cal package “SigmaPlot,” version 9.0 (SAS Institute Inc., 
Cary, NC, USA) [33].
Results
Hericium erinaceus mycelium (HEM) inhibits the cytotoxic 
effect of neuron cells in the MPTP‑treatment animal model
Our previous study demonstrated that H. erinaceus 
mycelium and its structural analog erinacine A have 
nerve-growth properties, allowing them to aid in the pre-
vention of ischemic injury to neurons in the central nerv-
ous system of excessive oxidative stress subjects [12, 13]. 
Based on these studies, we assayed whether H. erinaceus 
mycelium provides substantial therapeutic advantages 
by suppressing brain impairment in a mouse model that 
resembles PD. Figure  1 shows the neuroprotection of 
HEM in an MPTP-treated animal model. Figure 2 shows 
the expressions of the results of TUNEL as well as tyros-
ine hydroxylase (dopaminergic neurons). There was also 
a reduction in the number of positive TUNEL cells in 
the striatum and substantia nigra, a marker of apoptosis, 
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when the MPTP mice treated with HEM were compared 
with the untreated MPTP mice (MPTP = 38 ± 5; 10.76 
and 21.52  mg/day, HEM =  24 ±  3 and 7 ±  2, *  <0.05). 
Tyrosine hydroxylase (TH) is expressed exclusively in 
most dopaminergic neuronal cell types. TH is the enzyme 
responsible for the conversion of the amino acid l-tyros-
ine to dopamine, while PD can be indicated as a TH-
deficiency syndrome of the striatum. Immunoreactivity 
of phospho-Tyrosine hydroxylase was found to reside 
mostly in the brain striatum area in the MPTP group 
24  h after administering HEM. Quantification of the 
dopaminergic neuron cells in terms of pathology showed 
that the dosage of MPTP administration was inclined to 
decrease the number of normal neurons compared to 
the control group. However, a significant increase was 
found between the MPTP and MPTP  +  HEM (10.76 
and 21.52  mg/day) group (untreated MPTP  =  32  ±  5; 
HEM treated MPTP = 72 ± 6 # <0.05 and 116 ± 13) (see 
Fig. 2c).
HEM treatment‑attenuated brain protein ROS oxidants 
and behavioral impairment in mice with MPTP intoxication
In a previous study, an animal model of Parkinson’s 
disease showed the result of the presence of excessive 
free radicals after brain tissue damage; these have been 
reported to damage dopamine neurons due to dopamine 
formation for PD [23]. These findings demonstrated that 
HEM was able to inhibit oxidative nitrotyrosine proteins 
and lipid peroxidation 4-HNE, resulting in the dopa-
minergic nigrostriatal neurons’ apoptosis. This suggests 
that the ER stress effectors of CHOP via p38 MAPK 
may contribute to the neuroprotective effects by MPTP 
administration (Fig. 3, p < 0.05). Figure 4 shows the neu-
roprotective activities of HEM in an MPTP-treated ani-
mal model. Motor function of MPTP injection of HEM 
was also determined by a rotary rod apparatus, in com-
parison to an MPTP group. Five days after MPTP treat-
ment, the mice showed significant motor function, as 
indicated by a decrease in the time periods on a rotary 
rod at 6  days, as compared to the control group MPTP 
mice (p  <  0.05, n  =  6). Significant differences were 
found between the HEM-treated and MPTP groups. 
The HEM group showed reduced motor dysfunction 
in a dose-dependent manner compared to the MPTP 
group (p  <  0.01, n =  6; Fig.  3). Based on these studies, 
we tested whether HEM administration provided a pro-
tection of oxidative stress on densitometric analysis of 
neurotrophic factors in the brain striatum. As shown in 
Table 1, infusion of MPTP had a pro-inflammatory effect 
on brain injury, as shown through enzymatic analyses of 
the MPTP treatment group compared to a healthy con-
trol group. Dopamine, NGF and glutathione (GSH) levels 
were significantly lowered in the MPTP treatment group 
(MPTP infusion vs. normal saline infusion, p  <  0.05, 
n = 6). Neuron GSH levels have recently been established 
as an indicator of oxidative stress in various diseases. The 
administration of the HEM groups significantly (HEM 
treatment vs. MPTP infusion, *  <0.01, n  =  6) elevated 
dopamine, NGF and the GSH level in the MPTP group.
Inhibition effects of erinacine A treatment 
on MPP + ‑induced ROS‑related apoptosis and the ER 
stress‑signaling mechanisms
Our previous findings demonstrated the effects of the 
biological agent of erinacine A from HEM fractiona-
tion and its effect on ischemia reperfusion injury. This 
suggests that the inactivation of the iNOS/RNS and p38 
MAPK/CHOP pathways may contribute to the neu-
roprotective effects for both cortical and subcortical 
infarctions. MPTP exerts its neurotoxic effect through 
biological activation by MPP+, leading to mitochon-
drial energy loss, generation of toxic ROS and neu-
ron cell death [34]. To clarify whether erinacine A has 
an inhibitory effect on the MPP+ model of neuronal 
injury that is cytotoxic to N2a cells and the molecular 
mechanisms underlying the MPP+ -mediated activa-
tion of IRE1a-inducing Jun N-terminal kinase (JNK1/2) 
and p38 MAP Kinase (MAPK), we induced N2a cells to 
MPP+ for 24 h, performed MTT assays and examined 
the protein levels of the ER stress-signaling pathway. 
Significantly decreased cell death was found in the eri-
nacine A group compared to the MPP+ group (Fig. 5a). 
As shown in Fig.  5b, the extent of apoptosis of MPP+ 
induction was quantified as a percentage of annexin 
V-positive cells and shown as 20  %. Erinacine A treat-
ment of N2a cells also resulted in increased neuron 
(See figure on previous page.) 
Fig. 2 Effect of Hericium erinaceus mycelium (HEM) on brain histological examination in MPTP treated animal model. MPTP animal models (MPTP 
injection and brains harvested) were performed on mice described in “Methods” section. a Histological examination of brain were revealed to stria‑
tum and substantia nigra zones as indicated by immunohistochemical staining of TUNEL. Representative brain sections stained as saline infusion 
control group (I); Mice with MPTP injection (II); HEM treatment (10.76 and 21.52 mg/day) (III, IV); Apoptotic cells were measured under microscopy 
as described in “Methods” section. The MPTP group exhibited dopamine deficiency syndrome of the striatum, as indicated by apoptotic cells (filled 
arrow). Magnification, ×100. b Histological examination of brain were revealed in brain, as indicated by immunohistochemical staining of tyrosine 
Hydroxylase p‑Ser 31. Magnification, ×200. The cells were counted from 10 fields (200× magification) of each brain sample. c The results from 
statistical analysis are the means of cells and were calculated per microscope field from six animals per group. Data are expressed as mean ± SD of 
independent experiments. *p < 0.05, MPTP group versus MPTP + HEM group. #P < 0.05, MPTP group versus MPTP + HEM group
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survival by 6 and 3  %, respectively. Erinacine A might 
have neuroprotection effects on neuron injury caused 
by oxidative stress of MPP+.
Erinacine A prevented cell death and was involved in the 
modulation of IRE1α/ΤRΑF2 complex levels, as well 
as ER‑associated protein expression by MPP+ in neuron 
cells
Our results clearly showed that MPP+ resulted in neuron 
cell death and that oxidative damage was relative to the 
expression of Fas, Bax and CHOP, as well as to activation 
of the ER stress-signaling pathway, such as the p-JNK1/2, 
p38 MAPK and NF-κB triggering pathways, which may 
function downstream of the ER stress to induce apopto-
sis in response to neuronal damage, as an index of exces-
sive oxidative damage with Western blotting (Fig.  6a). 
Conversely, treatment with erinacine A also resulted in a 
significant inhibition of JNK1/2 and p38 phosphorylation 
and ER-associated protein expression for 24  h. In addi-
tion, erinacine A was also found to induce effects on the 
IRE1α/ΤRΑF2 association (Fig. 6). In order to verify the 
effects of oral administration of HEM and erinacine A on 
the relationships between neuroprotection, inflamma-
tion and ER stress in the brain, Fas protein was selected 
for further examination using immunohistochemistry 
assays in  vivo after MPTP injury and HEM treatment. 
As shown in Fig.  7, mice with MPTP impairment dem-
onstrated increased expression of Fas (CD95) in the 
brain tissue samples. In particular, HEM and relative 
erinacine A treatment resulted in a significant reduction 
of Fas expression. These results are consistent with the 
results in vitro, indicating that HEM is applicable when 
protecting MPTP-induced brain neuron injury. Taken 
together, the results and the data showed that H. erina-
ceus mycelium and relative erinacine A administration 
in neuron cells is essential to involvement in oxidative 











































Fig. 4 Effect of Hericium erinaceus mycelium (HEM) treatment on 
motor function by the rocking rotarod assessment of coordina‑
tion. Mean duration (in seconds) of the time spent on the rocking 
rotarod as a function of increasing motor function for MPTP and HEM 
administration mice. At 5 days after the MPTP injection, the mice 
exhibited a significant motor dysfunction as indicated by a decrease 
in the time period on rotarod. The mice with MPTP treated with 
HEM(III) and assessed by rotarod apparatus. Data were expressed as 
mean ± SD (n = 6/group). *p < 0.05, 4 days, control group versus 
MPTP and MPTP + HEM groups. #P < 0.05, 5 days, MPTP group 
versus MPTP + HEM groups. & P < 0.05, 5 days, MPTP group versus 
MPTP + HEM groups
Table 1 Biochemical effects of MPTP administration animal model by Hericium erinaceus mycelium
* P < 0.05, when compared with MPTP group
Neurotoxic effects of the striatum






Dopamine (ng/ml) 3.6 ± 0.15 1.7 ± 0.1 3.1 ± 0.1* 3.8 ± 0.1* 4.1 ± 0.1*
NGF (ng/ml) 2.8 ± 0.5 1.2 ± 0.1 1.9 ± 0.3* 2.3 ± 0.4* 2.7 ± 0.3*
GSH/mg 140 ± 11 62 ± 6 94 ± 8 134 ± 10 138 ± 8*
(See figure on previous page.) 
Fig. 3 Effect of Hericium erinaceus mycelium (HEM) on brain histological nitrotyrosine and 4‑HNE protein expression in MPTP animal model. 
Histological examination of brain were revealed to somata of dopamine neurons by immunohistochemical staining. a Mice were sacrificed and the 
brains were separated. Representative brain sections stained control group (I); Mice treated with MPTP at 6 days (I); HEM administration [10.76 (III) 
and 21.52 (IV) mg/day] staining of nitrotyrosine (a) and 4‑HNE (b) protein in brain tissue. c Evaluation of nuclear protein expression and nitrotyros‑
ine and 4‑HNE expression were quantitative in the striatum. The area of dopamine neurons positive stained area from the SN was evaluated from 
three randomly selected observation fields of each brain section. Quantitative of immunohistochemical proteins by average integrated optical 
density (AIOD). Positive stained area was evaluated from three randomly selected observation fields of each liver section. Data were expressed as 
mean ± SD (n = 6/group). *p < 0.05, nitrotyrosine expression, MPTP group versus MPTP + HEM group. #P < 0.05, 4‑HNE expression, MPTP group 
versus MPTP + HEM group













































Fig. 5 Effect of MPTP on assessment of cell viability in N2a cells for 24 h. a after 24 h their viability was measured using an MTT assay. b After an 
indicated treatment for 24 h, the cells were stained with FITC‑conjugated Annexin‑V and PI for flow cytometry analysis as described in “Methods” 
section. The percentages presented in each frame depicted the apoptotic cells. *p < 0.05, indicates significant difference compared to an untreated 
group of N2a
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stress-signaling MPP+ -mediated cell death along both 
IRE1α and JNK1/2/NF-κB-related pathways.
Discussion
ER stress-induced apoptosis is implicated in various 
pathological conditions, but the mechanisms of H. eri-
naceus mycelium on the suppression of oxidative stress 
and JNK/p38 MAPK as well as Fas, Bax and CHOP pro-
tein expression, which confer neuroprotection in PD 
involving ER stress–mediated signaling to neuron apop-
totic pathways, remain unclear. It has been previously 
reported that a number of H. erinaceus extracts, used 
as a medicinal mushroom, can improve sleep quality, 
ameliorate depression and neurodegenerative disease, 
and improve cognitive impairment [35]. Moreover, it 
was reported that polysaccharides purified from the liq-
uid culture broth of HEM and erinacine A enhanced the 
growth of mice adrenal nerve cells, improved the exten-
sion of neurite extension and expanded catecholamine 
in the brain of mice. Recently, studies were conducted 
on the synergistic effects of HEM extracts and exog-
enous NGF on neurite outgrowth in a glioma cell line. 
These studies demonstrate that the HEM extracts contain 
certain neuroactive components that induce NGF syn-
thesis and promote neurite outgrowth, which has been 
shown to be a mycelium- growth-associated metabolite 
that stimulates NGF synthesis in cultured astrocytes [7]. 
Using an in  vivo MPTP animal model and mouse neu-
ron cell culture MPP+ -induced apoptosis (Fig.  1), our 
in vivo data demonstrated that the dopaminergic lesions 
and oxidative stress in the striatum and substantia nigra, 
as well as motor disorder, were significantly decreased 
after treatment with HEM (Figs. 2, 3, 4). In addition, we 
deployed several neuron cell death assays to confirm that 
the MPP+ damage, as measured by brain neuron death, 
is significantly decreased with erinacine A treatment at 
the concentration of 5 μM for 24 h in N2a cells (Fig. 5).
Studies have shown that ER stress- and inflammation-
induced apoptosis is a key pathogenic event in disease 
processes as divergent as metabolism disease, cancer, 
hepatitis, heart disease and neurological diseases [5, 8, 
22, 36]. The overall objective of this study made it neces-
sary to develop more effective drugs from natural com-
pounds of edible mushrooms to prevent neuronal death 
at high MPP+ exposures related to the mechanism of 
ER stress-induced apoptosis. The specific goal was link-
ing upstream ER stress-mediated events to downstream 
apoptosis execution pathways in a model involving the 
JNK1/2, p38, NF-kB and CHOP pathways. Of current 
interest is the concept that prolonged CHOP expression 
leads to the release of ER calcium stores resulting from 
ER stress-induced expression of the Fas death receptor 
and Bax mitochondrial pathways of apoptosis through 
a pathway involving JNK and p38. Figure  6 shows that 
treatment of N2a cells with erinacine A increased the 
level of phosphorylated JNK and p38 MAPK as a result 
of an upregulation of CHOP and NFκB at 24  h, as well 
as a decrease in the Fas/Bax expression and IRE1α/
TRAF2 complex interaction as early as 3  h. Our results 











































































Fig. 6 Erinacine A mediated and ER‑associated proteins expres‑
sion between untreated (control) and treated (MPP+) in N2a cells. a 
Nuclear and whole cell lysate proteins were prepared and ana‑
lyzed by Immunoblotting, using antisera to detect Fas, Bax, p‑JNK, 
p‑p38,CHOP, NF‑kB p65, p‑IKB‑b and IRE1a (b‑actin and Histone H1 
served as the internal control). The association of TRAF2 with IRE1‑a 
was determined by immunoprecipitation with TRAF2 followed by 
western blot with anti‑IRE1‑a antibody. b Protein levels were quanti‑
fied by densitometric analysis with the control being set at 100 %. 
Data presented in western blot are derived from a representative 
study, and comparisons of protein expression are calculated from 
three independent experiments. *P < 0.05, when compared with 
control untreated group
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neuron damage by inactivating oxidative stress-depend-
ent CHOP expression. We also showed that both the Fas 
and Bax pathways, through induction of the Fas receptor 
itself and the mitochondrial pathway by MPP+ , and then 
specifically erinacine A, reduced the production of the 
ER stress-signaling pathway in dose-relative inhibition. 
Moreover, our histopathological and immunohistochem-
ical assays provide unique evidence suggesting that HEM 
is able to suppress neuron impairment in MPTP mice 
at doses below the safe starting-dose range (Conversion 
of Animal Doses), and that this involves the significant 
inhibition of neuron death and Fas expression (Fig.  5). 
These findings provide an integrated, unique mecha-
nism linking the ER stress to apoptosis, and suggest 
that it is feasible to determine whether H. erinaceus and 



























































Fig. 7 Effect of Hericium erinaceus mycelium (HEM) on brain histological Fas protein expression in MPTP treated animal model. Histological exami‑
nation of brain were revealed to striatum and substantia nigra zones as indicated by immunohistochemical staining. Representative brain sections 
stained as saline infusion control group (I); Mice with MPTP injection (II); HEM treatment (5.38, 10.76 and 21.52 mg/day) (III, IV, V); Erinacine A (i.p. VI); 
The results from statistical analysis are the means of cells and were calculated per microscope field from six animals per group. Data are expressed 
as mean ± SD of independent experiments. *p < 0.05, MPTP group versus MPTP + HEM group and MPTP + EA group
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neuroprotective effects for intervention directed against 
PD’s ER stress-induced apoptosis.
Studies have shown that natural phytochemicals from 
certain plants have the capability to exert neuroprotec-
tive effects in various experimental models of neuro-
logical disorders, and also to have cytotoxic effects on 
cancer cells [13, 37]. Furthermore, reducing oxidative 
stress-induced free radicals via an antioxidant effect 
has been shown to protect against the neuronal damage 
caused by neurotrophin deficiencies and toxin-induced 
degenerative diseases in response to chemopreven-
tive drugs, such as dietary phytochemicals, phenols, 
alkaloids, flavonoids and mushrooms [38]. Moreo-
ver, finding a suitable neuroprotective agent is needed 
since this is a very important property with regard to 
its ability to cross the blood–brain barrier (BBB). To 
validate these findings, further study of H. erinaceus 
is needed to determine whether there are mediated 
actions to reach the target sites of the CNS in mice. 
However, phytochemicals that regulate neurodegenera-
tive disease by targeting neurotrophins might provide a 
promising future. Both NGF and BDNF are expressed 
in dopaminergic neurons, suggesting that these act as a 
survival factor for the trophic support of neurons. Phy-
tochemicals that potentiate neurotrophins and activate 
Trk receptors may serve to prohibit the onset of neu-
rodegenerative PD [39]. On the other hand, it has been 
shown that JNK and p38 MAPK stress protein kinases 
are involved in inflammation and oxidative stress in 
neurodegenerative neuronal death in PD [36]. Our 
results showed that the upregulation of NGF protein 
and dopamine affected the striatum neuron cell with 
an increase of the antioxidative indicator GSH; these 
resulted in inhibitors targeting JNK and p38MAPK, 
preceded by the administration of H. erinaceus myce-
lium (Table 1; Fig. 6).
Conclusion
In this study, we evaluated the molecular mechanisms 
underlying the roles of H. erinaceus against MPTP-
induced neurotoxicity. Consequently, based on MPTP-
treated mice, our results imply the possibility of a toxic 
effect of MPTP, a food provided by the mushroom com-
ponents of H. erinaceus, on N2a cells and enable the 
evaluation of the protective ability and the underlying 
mechanisms against MPP+ cytotoxicity. In  vivo study 
demonstrated that H. erinaceus mycelium decreased 
the brain dopamine neuronal loss and motor function. 
Our study showed that erinacine A inhibited the neu-
ron cell apoptosis as a result of oxidative stress signal-
ing and the JNK/p38/NF-κB/CHOP/Fas/Bax pathways 
(Fig.  8). These results provide insights into the neu-
roprotective activity of erinacine A of the Hericium 
erinaceus mycelium, which thus may be promising can-
didates for the treatment of neurodegenerative diseases 
such as PD.
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